IA Trial Radar

Discutamos y exploremos los ensayos clínicos con Centro Oncológico MD Anderson como patrocinador principal o colaborador.

Puedo ayudarle a entender sus condiciones de salud, tratamientos o encontrar ensayos clínicos cercanos.
Nuestra herramienta de búsqueda solo admite inglés. Para búsquedas y discusiones en otros idiomas, use la IA Trial Radar o seleccione los filtros de condición médica y ubicación a continuación.
43 ensayos clínicos
 
Estado (Por defecto)
Aún No Recluta, Reclutando, Activo, No Reclutando
×
 
Tipo de estudio
Intervencionista
×
 
Título del estudio
Estado
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum NCT07509008
Aún no recluta
A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL) NCT07508995
Aún no recluta
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML NCT07508982
Aún no recluta
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer NCT07500298
Aún no recluta
Radiofrequency Ablation For Recurrent Parathyroid Carcinoma NCT07475780
Aún no recluta
A Multi-Center Single-Arm Phase 2 Trial Of Zanzalintinib In Combination With Cemiplimab In BRAF Wild-Type Anaplastic Thyroid Cancer: The ZEPHYR Trial NCT07470489
Aún no recluta
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System NCT07444645
Aún no recluta
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies NCT07444632
Aún no recluta
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas NCT07444619
Aún no recluta
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases NCT07444606
Aún no recluta
Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma NCT07438626
Aún no recluta
A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia NCT07428486
Aún no recluta
Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease NCT07415018
Aún no recluta
Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer NCT07415005
Aún no recluta
Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma NCT07414979
Aún no recluta
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") NCT07411599
Aún no recluta
Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia NCT07411586
Aún no recluta
Trial of Spiritual Care Interventions for Patients With Cancer NCT07408310
Aún no recluta
Estudio de fase 2 para la optimización de la terapia sistémica complementaria en pacientes HER2+, ensayo MolecularPCR NCT07407920
Activo, no reclutando
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) NCT07401875
Reclutando
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms NCT07382817
Reclutando
Estudio de fase 2 del cebado inmunitario inducido por radioterapia para potenciar elranatamab (Elra) en el mieloma múltiple en recaída o refractario (MMRR) con enfermedad extramedular (EEM) y enfermedad paramedular (EPM) "PRIME-EMD-PMD" NCT07382739
Aún no recluta
Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial NCT07382726
Aún no recluta
Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System NCT07382557
Reclutando
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss NCT07382544
Reclutando
Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer NCT07377526
Aún no recluta
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer NCT07377006
Aún no recluta
A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses NCT07369050
Aún no recluta
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations NCT07325253
Reclutando
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer NCT07318389
Aún no recluta
IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention NCT07318363
Aún no recluta
Estudio de fase Ib de avutometinib, defactinib y everolimus en cáncer de endometrio con mutación en la vía RAS NCT07318324
Aún no recluta
Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma NCT07316010
Aún no recluta
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia NCT07311746
Aún no recluta
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE) NCT07298096
Reclutando
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma NCT07283731
Aún no recluta
Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma NCT07283679
Aún no recluta
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial NCT07283653
Reclutando
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia NCT07283640
Aún no recluta
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase NCT07269470
Aún no recluta
Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study NCT07257068
Aún no recluta
Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study NCT07257055
Aún no recluta
A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial NCT07246954
Reclutando